|
| 36054490 | Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer. | Int J Cancer | 2023 |
| 36054490 | Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer. | Int J Cancer | 2023 |
| 37790315 | Prediction of cancer treatment response from histopathology images through imputed transcriptomics. | Res Sq | 2023 |
| 36801811 | Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. | Ann Rheum Dis | 2023 |
| 37790315 | Prediction of cancer treatment response from histopathology images through imputed transcriptomics. | Res Sq | 2023 |
| 36801811 | Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. | Ann Rheum Dis | 2023 |
| 34695605 | The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? | J Thorac Oncol | 2022 |
| 36164359 | Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist's perspective. | Mediastinum | 2022 |
| 35440132 | Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. | Nat Commun | 2022 |
| 35380721 | Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors. | Oncologist | 2022 |
| 35565190 | Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword. | Cancers (Basel) | 2022 |
| 35793869 | Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature. | J Immunother Cancer | 2022 |
| 36582974 | The therapeutic relevance of a <i>BRCA2</i> mutation in a patient with recurrent thymoma: a case report. | Mediastinum | 2022 |
| 35227908 | Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group. | J Thorac Oncol | 2022 |
| 34695605 | The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? | J Thorac Oncol | 2022 |
| 35380721 | Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors. | Oncologist | 2022 |
| 35440132 | Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. | Nat Commun | 2022 |
| 35793869 | Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature. | J Immunother Cancer | 2022 |
| 35565190 | Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword. | Cancers (Basel) | 2022 |
| 36582974 | The therapeutic relevance of a <i>BRCA2</i> mutation in a patient with recurrent thymoma: a case report. | Mediastinum | 2022 |
| 36164359 | Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist's perspective. | Mediastinum | 2022 |
| 35227908 | Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group. | J Thorac Oncol | 2022 |
| 33150828 | COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India. | Pediatr Hematol Oncol | 2021 |
| 33641717 | Immunotherapy for Thymic Cancers: A Convoluted Path Toward a Cherished Goal. | J Thorac Oncol | 2021 |
| 34267468 | Haploidentical Hematopoietic Stem Cell Transplantation in Leukemia's: Experience from a Cancer Center in India. | Indian J Hematol Blood Transfus | 2021 |
| 33504652 | Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. | Sci Transl Med | 2021 |
| 33150828 | COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India. | Pediatr Hematol Oncol | 2021 |
| 34514444 | Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors. | JTO Clin Res Rep | 2021 |
| 34568223 | Autologous Stem Cell Transplantation in Testicular Germ Cell Tumor-Preliminary Experience from a Single Center. | South Asian J Cancer | 2021 |
| 34957421 | Reply to K. Takada et al. | JTO Clin Res Rep | 2021 |
| 34541456 | The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review. | Mediastinum | 2021 |
| 33641717 | Immunotherapy for Thymic Cancers: A Convoluted Path Toward a Cherished Goal. | J Thorac Oncol | 2021 |
| 33504652 | Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. | Sci Transl Med | 2021 |
| 34957421 | Reply to K. Takada et al. | JTO Clin Res Rep | 2021 |
| 34514444 | Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors. | JTO Clin Res Rep | 2021 |
| 34541456 | The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review. | Mediastinum | 2021 |
| 34568223 | Autologous Stem Cell Transplantation in Testicular Germ Cell Tumor-Preliminary Experience from a Single Center. | South Asian J Cancer | 2021 |
| 34267468 | Haploidentical Hematopoietic Stem Cell Transplantation in Leukemia's: Experience from a Cancer Center in India. | Indian J Hematol Blood Transfus | 2021 |
| 32483558 | Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer. | Cell Rep Med | 2020 |
| 32019188 | Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)<sub>n</sub> Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors? | Int J Mol Sci | 2020 |
| 32483558 | Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer. | Cell Rep Med | 2020 |
| 32568452 | Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial. | Pediatr Blood Cancer | 2020 |
| 32559556 | Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy. | Leuk Res | 2020 |
| 33219092 | Efficacy and immune-related adverse event associations in avelumab-treated patients. | J Immunother Cancer | 2020 |
| 35118275 | Case presentations and recommendations from the 2018 ITMIG Annual Meeting. | Mediastinum | 2020 |
| 34589981 | JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted <i>Listeria monocytogenes</i>-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies. | JTO Clin Res Rep | 2020 |
| 34589945 | Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation. | JTO Clin Res Rep | 2020 |
| 34589936 | Appendiceal Metastasis From Thymic Carcinoma: An Unusual Presentation of a Rare Cancer. | JTO Clin Res Rep | 2020 |
| 35118275 | Case presentations and recommendations from the 2018 ITMIG Annual Meeting. | Mediastinum | 2020 |
| 34589981 | JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted <i>Listeria monocytogenes</i>-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies. | JTO Clin Res Rep | 2020 |